| Product |
CAS |
Molecular formula |
More |
| Moxifloxacin ep impurity a |
151213-15-9 |
C20H21F2N3O3 |
More |
| Moxifloxacin ep impurity b |
1029364-73-5 |
C22H27N3O5 |
More |
| Moxifloxacin optical enantiomer |
268545-13-7 |
C21H24FN3O4 |
More |
| Lansoprazole ep impurity a |
953787-54-7 |
C16H14F3N3O4S |
More |
| Lansoprazole ep impurity b |
131926-99-3 |
C16H14F3N3O3S |
More |
| Esomeprazole ep imuprity d |
88546-55-8 |
C17H19N3O4S |
More |
| Esomeprazole ep imuprity e |
176219-04-8 |
C17H19N3O4S |
More |
| Fluconazole ep impurity b |
871550-15-1 |
C15H14FN9O |
More |
| Fluconazole ep impurity c |
514222-44-7 |
C10H8N6 |
More |
| Fluconazole ep impurity d |
81886-51-3 |
C13H13FN6O |
More |
| Pitavastatin enantiomer |
254452-86-3 |
C25H24FNO4 |
More |
| Pitavastatin diastereomer |
769908-13-6 |
C25H24FNO4 |
More |
| Pitavastatin diastereomer |
688735-41-3 |
C25H24FNO4 |
More |
| Benzenamine,3-ethoxy-n-phenyl |
43035-14-9 |
C14H15NO |
More |
| (2R,3s)-2-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorop |
171482-05-6 |
C20H18F7NO2.HCl |
More |
| 2-Chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
132813-14-0 |
C17H17ClFN |
More |
| 5-Bromo-2-picoline |
340-13-5 |
|
More |
| 4-Methyl-3-nitropyridine hydrochloride |
856835-53-5 |
C6H6N2O2路HCl |
More |
| Ethyl-4-1-2-(4-[benzopyrazine base)ethyl]]-3-2-erbenjipyrrole |
15083-72-4 |
|
More |
| 4-Bromo-4-iodobiphenyl |
105946-82-5 |
C12H8BrI |
More |
